Orexigen soars on Takeda deal; drug indexes slip 0
Posted on
September 03, 2010 by
admin
Orexigen soars on Takeda deal; drug indexes slip
BOSTON (MarketWatch) — Orexigen Therapeutics was in the spotlight early Thursday as shares of the biotech group soared on news that Japanese pharmaceutical giant Takeda Pharmaceutical Co. has agreed to commercialize Orexigen’s new diet drug Contrave in North America, if and when it receives regulatory approval. Orexigen expects to receive a decision from the U.S. Food and Drug Administration on …
Read more on Market Watch
